3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
70
Triple Negative Breast Neoplasms
5
Carcinoma, Intraductal, Noninfiltrating
4
Inflammatory Breast Neoplasms
3
Seroma
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Invasive Breast Cancer
2
Carcinoma, Ductal, Breast
2
Breast Cancer Invasive
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Premenopausal Breast Cancer
1
Patient Preference
1
Pain, Postoperative
1
Pain
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Myofibroma
1
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Inflammation
1
Hereditary Breast and Ovarian Cancer Syndrome
1
HER2-positive Early Breast Cancer
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Interventions
Zoledronic Acid
8
Psychiatric Rehabilitation
6
Analgesia
5
Acupuncture Therapy
5
Therapeutics
4
Bupivacaine
4
Surveys and Questionnaires
3
Radiotherapy
3
Ketamine
3
Early Intervention, Educational
3
Control Groups
3
Calcium
3
Yoga
2
Pregabalin
2
Music Therapy
2
Melatonin
2
Letrozole
2
Interviews as Topic
2
Fentanyl
2
Fatty Acids, Omega-3
2
Duloxetine Hydrochloride
2
Calcium Gluconate
2
Art Therapy
2
strontium chloride
1
pegfilgrastim
1
ixabepilone
1
exemestane
1
esmolol
1
cyclobenzaprine
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain
×
Surgical Procedures, Operative
×
Breast
×
Clear all
NCT04086394
2020-02-20
PECS
Main Line Health
Phase NA
Unknown
130 enrolled